Sign In
to Vote &
Create Storyboards.
 
(New York Genome Center) Dr. Sanjana's three-year grant was awarded for his research entitled "A human T cell genetic screen for melanoma immunotherapy," which aims to characterize genetic mutations that lead to immunotherapy resistance in melanoma.
0
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}
    {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}
  • Create Storyboard